Abstract
We have investigated modulation of voltage-gated calcium channels by nociceptin (ORL1) receptors. In rat DRG neurons and in tsA-201 cells, nociceptin mediated a pronounced inhibition of N-type calcium channels, whereas other calcium channel subtypes were unaffected. In tsA-201 cells, expression of N-type channels with human ORL1 resulted in a voltage-dependent G-protein inhibition of the channel that occurred in the absence of nociceptin, the ORL1 receptor agonist. Consistent with this observation, native N-type channels of small nociceptive dorsal root ganglion (DRG) neurons also had tonic inhibition by G proteins. Biochemical characterization showed the existence of an N-type calcium channel–ORL1 receptor signaling complex, which efficiently exposes N-type channels to constitutive ORL1 receptor activity. Calcium channel activity is thus regulated by changes in ORL1 receptor expression, which provides a possible molecular mechanism for the development of tolerance to opioid receptor agonists.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beedle, A.M. & Zamponi, G.W. Modulation of high voltage–activated calcium channels by G protein–coupled receptors. in Calcium Channel Pharmacology (ed., McDonough, S.) (Kluwer Academic/Plenum Publishing, New York, 2003).
Bunzow, J.R. et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347, 284–288 (1994).
Bertorelli, R. et al. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain. Br. J. Pharmacol. 128, 1252–1258 (1999).
Ahmadi, S., Liebel, J.T. & Zeilhofer, H.U. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin. Eur. J. Pharmacol. 412, 39–44 (2001).
Mollereau, C., Moisand, C., Butour, J.L., Parmentier, M. & Meunier, J.C. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett. 395, 17–21 (1996).
Xu, X., Hao, J.W. & Wiesenfeld-Hallin, Z. Nociceptin of antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7, 2092–2094 (1996).
Knoflach, F., Reinscheid, R.K., Civelli, O. & Kemp, J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16, 6657–6664 (1996).
Connor, M. & Christie, M.J. Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. 15, 47–58 (1998).
Larsson, K.P., Olsen, U.B. & Hansen, A.J. Nociceptin is a potent inhibitor of N-type Ca2+ channels in rat sympathetic ganglion neurons. Neurosci. Lett. 296, 121–124 (2000).
Morikawa, H. et al. Nociceptin receptor-mediated Ca2+ channel inhibition and its desensitization in NG108-15 cells. Eur. J. Pharmacol. 351, 247–252 (1998).
Abdulla, F.A. & Smith, P.A. Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J. Neurosci. 17, 8721–8728 (1997).
Borgland, S.L., Connor, M. & Christie, M.J. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J. Physiol. 536, 35–47 (2001).
Zamponi, G.W. Determinants of G protein inhibition of presynaptic calcium channels. Cell. Biochem. Biophys. 34, 79–94 (2001).
Koch, W.J., Hawes, B.E., Inglese, J., Luttrell, L.M. & Lefkowitz, R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signalling. J. Biol. Chem. 269, 6193–6197 (1994).
Albert, P.R., Morris, S.J., Ghahremani, M.H., Storring, J.M. & Lembo, P.M. A putative alpha-helical G beta gamma-coupling domain in the second intracellular loop of the 5-HT1A receptor. Ann. NY Acad. Sci. 861, 146–161 (1998).
Lembo, P.M., Ghahremani, M.H., Morris, S.J. & Albert, P.R. A conserved threonine residue in the second intracellular loop of the 5–hydroxytryptamine 1A receptor directs signalling specificity. Mol. Pharmacol. 52, 164–171 (1997).
Wu, X., Kushwaha, N., Albert, P.R. & Penington, N.J. A critical protein kinase C phosphorylation site on the 5-HT(1A) receptor controlling coupling to N-type calcium channels. J. Physiol. 538, 41–51 (2002).
Arnot, M.I., Stotz, S.C., Jarvis, S.E. & Zamponi, G.W. Differential modulation of N-type 1B and P/Q-type 1A calcium channels by different G protein subunit isoforms. J. Physiol. 527, 203–212 (2000).
Beech, D.J., Bernheim, L. & Hille, B. Pertussis toxin and voltage dependence distinguish multiple pathways modulating calcium channels of rat sympthetic neurons. Neuron 8, 90–106 (1992).
Luebke, J.I. & Dunlap, K.I. Sensory neuron N-type calcium currents are inhibited by both voltage-dependent and -independent mechnaisms. Pflugers Arch. 428, 499–507 (1994).
Kammermeier, P.J., Ruiz-Valesco, V. & Ikeda, S.R. A voltage-independent calcium current inhibitory pathway activated by muscarinic agonists in rat sympathetic neurons requires both Gαq/11 and Gβγ. J. Neurosci. 20, 5623–5629 (2000).
Schiff, M.L. et al. Tyrsoine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. Nature 408, 723–727 (2000).
Diverse-Pieluissi, M., Goldsmith, P.K. & Dunlap, K. Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunits. Neuron 14, 191–200 (1995).
De Waard, M. et al. Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature 385, 446–450 (1997).
Herlitze, S. et al. Modulation of Ca2+ channels by G protein βγ subunits. Nature 380, 258–262 (1996).
Ikeda, S.R. Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits. Nature 380, 255–258 (1996).
Zamponi, G.W., Bourinet, E., Nelson, D., Nargeot, J. & Snutch, T.P. Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit. Nature 385, 442–446 (1997).
Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G protein-coupled receptors: cause of disease and common property of wild-type receptors. Nauyn Schmiedebergs Arch. Pharmacol. 366, 381–416 (2002).
Davare, M.A. et al. A beta2 adrenergic receptor signalling complex assembled with the Ca2+ channel Cav1.2. Science 293, 98–101 (2001).
Lavine, N. et al. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277, 46010–46019 (2002).
Emmerson, P.J. & Miller, R.J. Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J. Physiol. 517, 431–445 (1999).
Meis, S. & Pape, H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 532, 701–712 (2001).
Tallent, M.K., Madamba, S.G. & Siggins, G.R. Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms. J. Neurosci. 21, 6940–6948 (2001).
Venkatesan, P., Wang, J., Evans, C., Irnaten, M. & Mendelowitz, D. Nociceptin inhibits gamma-aminobutyric acidergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus. J. Pharmacol. Exp. Ther. 300, 78–82 (2002).
Monteillet-Agius, G., Fein, J., Anton, B. & Evans, C.J. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J. Comp. Neurol. 399, 373–383 (1998).
Neal, C.R. et al. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406, 503–547 (1999).
Wick, M.J. et al. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res. 27, 37–44 (1994).
Manabe, T. et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394, 577–581 (1998).
Briscini, L., Corradini, L., Ongini, E. & Bertorelli, R. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur. J. Pharmacol. 447, 59–65 (2002).
Gouarderes, C., Tafani, J.A., Meunier, J., Jhamandas, K. & Zajac, J. Nociceptin receptors in the rat spinal cord during morphine tolerance. Brain Res. 838, 85–94 (1999).
Jia, Y., Linden, D.R., Serie, J.R. & Seybold, V.S. Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci. Lett. 250, 21–24 (1998).
Kest, B. et al. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neurosci. 104, 217–222 (2001).
Ueda, H., Inoue, M., Takeshima, H. & Iwasawa, Y. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J. Neurosci. 20, 7640–7647 (2000).
Latour, I., Hamid, J., Beedle, A.M., Zamponi, G.W. & Macvicar, B.A. Expression of voltage-gated Ca2+ channel subtypes in cultured astrocytes. Glia 41, 347–353 (2003).
Beedle, A.M., Hamid, J. & Zamponi, G.W. Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J. Membr. Biol. 187, 225–238 (2002).
Monteil, A. et al. Specific properties of T-type calcium channels generated by the human alpha 1I subunit. J. Biol. Chem. 275, 16530–16535 (2000).
Magga, J.M., Jarvis, S.E., Arnot, M.I., Zamponi, G.W. & Braun, J.E. Cysteine string protein regulates G protein modulation of N-type calcium channels. Neuron 28, 195–204 (2000).
Jarvis, S.E., Magga, J.M., Beedle, A.M., Braun, J.E. & Zamponi, G.W. G protein modulation of N-type calcium channels is facilitated by physical interactions between syntaxin 1A and Gbetagamma. J. Biol. Chem. 275, 6388–6394 (2000).
Ouardouz, M. et al. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 40, 56–63 (2003).
Kaneko, S. et al. Identification and characterization of novel human Cav2.2 (alpha1B) calcium channel variants lacking the synaptic protein interaction site. J. Neurosci. 22, 82–92 (2002).
Acknowledgements
This work was supported by an operating grant to G.W.Z. from the Canadian Institutes of Health Research (CIHR). G.W.Z. is a CIHR Investigator and an Alberta Heritage Foundation for Medical Research (AHFMR) senior scholar. A.M.B. held studentship awards from AHFMR and the Natural Sciences and Engineering Research Council. C.J.D. is the recipient of an AHFMR studentship, C.A. holds postdoctoral fellowships from the AHFMR and the Heart and Stroke Foundation of Canada. E.B. is supported by the IUD foundation and the PICS program of the CNRS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Beedle, A., McRory, J., Poirot, O. et al. Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 7, 118–125 (2004). https://doi.org/10.1038/nn1180
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn1180
This article is cited by
-
Trace amine-associated receptor 1 regulation of Kv1.4 channels in trigeminal ganglion neurons contributes to nociceptive behaviors
The Journal of Headache and Pain (2023)
-
Regulation of N-type calcium channels by nociceptin receptors and its possible role in neurological disorders
Molecular Brain (2022)
-
Opioid Receptor Regulation of Neuronal Voltage-Gated Calcium Channels
Cellular and Molecular Neurobiology (2021)
-
Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors
Molecular Brain (2019)
-
The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells
BMC Complementary and Alternative Medicine (2018)